Vertex Pharmaceuticals Inc

DUS:VX1

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is VX1's stock price target?

Price Target

492.01 EUR

According to Wall Street analysts, the average 1-year price target for VX1 is 492.01 EUR with a low forecast of 307.67 EUR and a high forecast of 595.85 EUR.

What is the Revenue forecast for Vertex Pharmaceuticals Inc?

Projected CAGR

10%

Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.

What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?

Projected CAGR

10%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 10%.

What is the Operating Income forecast for Vertex Pharmaceuticals Inc?

Projected CAGR

15%

Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 8 years is 15%.

What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?

Projected CAGR

21%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 21%.

What is the Net Income forecast for Vertex Pharmaceuticals Inc?

Projected CAGR

14%

The compound annual growth rate for Net Income over the next 8 years is 14%.